When Jill decided to return to school to become an advanced practitioner, she sought my counsel. Going back to school after ...

HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

Unplugging from digital noise helped me find peace, clarity and room for growth during a season of emotional and mental ...

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...

The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after ...

Mikela Pettigrew, B.S.N., RN, OCN,, exemplifies extraordinary compassion and dedication. Every day, she fulfills a promise ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...